Diabetic ketoacidosis is an acute, potentially life-threatening metabolic complication of diabetes characterized by hyperglycemia, insulin deficiency, ketone body production, and anion-gap metabolic acidosis. It most commonly occurs in type 1 diabetes but can also occur in type 2 diabetes under severe physiologic stress. Prompt recognition and treatment are essential to reduce morbidity and mortality.
Recent studies reveal AI chatbots face significant challenges in medical applications, with one study showing ChatGPT Health under-triaged 51.6% of emergency cases. Cancer patients using an AI chatbot experienced 22% withdrawal rates due to usability issues, while medical researchers show cautious adoption with 40.3% reporting AI use in research.
Two recent clinical trials found that adding immunotherapy to standard chemoradiation did not improve survival for patients with limited-stage small-cell lung cancer or high-risk HPV-positive oropharyngeal cancer, though both studies revealed important insights about treatment delivery and radiation scheduling.
New analysis suggests leptin hormone could normalize blood sugar in type 1 diabetes by acting on the brain, potentially offering an alternative to daily insulin injections based on research dating back to 2011.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07483879 |
Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes |
RECRUITING | |
| NCT07467616 |
Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis. |
COMPLETED | NA |
| NCT07423559 |
Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients |
COMPLETED | NA |
| NCT07193069 |
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning |
RECRUITING | |
| NCT07167693 |
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes |
RECRUITING | PHASE1/PHASE2 |
| NCT07127406 |
Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor Users |
ACTIVE_NOT_RECRUITING | |
| NCT06955416 |
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis |
RECRUITING | PHASE2/PHASE3 |
| NCT06748365 |
Serum Ferritin and Prognosis of DKA |
RECRUITING | |
| NCT06693115 |
Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis |
WITHDRAWN | NA |
| NCT06599203 |
Children with Diabetic Ketoacidosis |
NOT_YET_RECRUITING |
